https://classic.clinicaltrials.gov/ct2/show/NCT05643729
Phase 1
The Safety and Feasibility of UMC119-06 Cell Therapy (Mesenchymal Stem Cells) in Subjects With Chronic Obstructive Pulmonary Disease
https://clinicaltrials.gov/ct2/show/NCT04206007?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease The Safety and Feasibility of UMC119-06 Cell Therapy in Subjects With Chronic Obstructive Pulmonary Disease Condition : Chronic Obstructive Pulmonary Disease Moderate Intervention : Biological: UMC119-06 Sponsor : Meridigen Biotech Co., Ltd. Not yet recruiting NCT04206007 Fri, 20 Dec 2019 12:00:00 EST
Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)
https://clinicaltrials.gov/ct2/show/NCT04047810?type=Intr&cond=COPD&sfpd_d=14&sel_rss=new14 Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD) Condition : Chronic Obstructive Pulmonary Disease Intervention : Biological: Mesenchymal Stem Cells Sponsor : Mayo Clinic Not yet recruiting NCT04047810 Wed, 07 Aug 2019 12:00:00 EDT
Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects
https://clinicaltrials.gov/ct2/show/NCT04032535 Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects (CHF6523)
Safety and Tolerability of MEDI3506 in Healthy Subjects, in Subjects With COPD and Healthy Japanese Subjects
https://clinicaltrials.gov/ct2/show/NCT03096795 Safety and Tolerability of MEDI3506 in Healthy Subjects, in Subjects With COPD and Healthy Japanese SubjectsClinicalTrials.gov Identifier: NCT03096795 Recruitment Status : Recruiting First Posted : March 30, 2017 Last Update Posted : January 8, 2019 See Contacts and Locations Sponsor: MedImmune LLC Information provided by (Responsible Party): MedImmune LLC Study Details Tabular ViewNo Results […]
Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients
https://clinicaltrials.gov/ct2/show/NCT03781895?type=Intr&cond=COPD&phase=01234&sfpd_d=14&sort=nwst&sel_rss=new14 Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients Condition : Stable COPD Patients Intervention : Drug: Cholecalciferol Sponsor : Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed NCT03781895 Thu, 20 Dec 2018 12:00:00 EST >>> updated dec 25, completed
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders
https://clinicaltrials.gov/ct2/show/NCT02946658?type=Intr&cond=COPD&phase=01234&lupd_s=10%2F25%2F2018&lupd_d=14&sort=nwst Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders Condition : Lung Disease Interventions : Procedure: lipoaspiration; Procedure: ADcSVF; Procedure: Normal Saline IV Sponsors : Healeon Medical Inc; Terry, Glenn C., M.D. Recruiting NCT02946658 Thu, 27 Oct 2016 12:00:00 EDT
Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD
https://clinicaltrials.gov/ct2/show/NCT03655795?type=Intr&cond=COPD&phase=01234&lupd_s=10%2F23%2F2018&lupd_d=14&sort=nwst Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD Condition : COPD Intervention : Biological: Bronchial basal cells Sponsors : Ruijin Hospital; Regend Therapeutics Not yet recruiting NCT03655795 Fri, 31 Aug 2018 12:00:00 EDT
